(Q42277972)

19 October 2017

title

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa (English)

1 reference

19 October 2017

0 references

human papilloma virus

0 references

cervix uterine cancer

1 reference

10

Wim Quint

1 reference

19 October 2017

Lynette Denny

1

1 reference

19 October 2017

Isaac Adewole

2

1 reference

19 October 2017

Rose Anorlu

3

1 reference

19 October 2017

Greta Dreyer

4

1 reference

19 October 2017

Manivasan Moodley

5

1 reference

19 October 2017

Trudy Smith

6

1 reference

19 October 2017

Leon Snyman

7

1 reference

19 October 2017

Edwin Wiredu

8

1 reference

19 October 2017

Anco Molijn

9

1 reference

19 October 2017

Gunasekaran Ramakrishnan

11

1 reference

19 October 2017

Johannes Schmidt

12

1 reference

19 October 2017

Denny, L.

0 references

Adewole, I.

0 references

Anorlu, R.

0 references

Dreyer, G.

0 references

Moodley, M.

0 references

Smith, T.

0 references

Snyman, L.

0 references

Wiredu, E.

0 references

Molijn, A.

0 references

Quint, W.

0 references

Ramakrishnan, G.

0 references

Schmidt, J.

0 references

language of work or name

English

0 references

publication date

14 November 2013

1 reference

International Journal of Cancer

19 October 2017

2014

0 references

published in

1 reference

19 October 2017

volume

134

1 reference

19 October 2017

issue

6

1 reference

19 October 2017

page(s)

1389-1398

1 reference

http://ugspace.ug.edu.gh/handle/123456789/25191

19 October 2017

exact match

0 references

cites work

Worldwide burden of cervical cancer in 2008.

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

Cervical cancer treatment in Africa

21 January 2018

1 reference

Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review

21 January 2018

1 reference

Part I: Cancer in Indigenous Africans--burden, distribution, and trends.

21 January 2018

1 reference

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

Human papillomavirus and cervical cancer

21 January 2018

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

Preventable exposures associated with human cancers

21 January 2018

1 reference

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

21 January 2018

1 reference

History of the FIGO cancer staging system.

21 January 2018

1 reference

Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping

21 January 2018

1 reference

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

21 January 2018

1 reference

Human Papillomavirus type distribution in invasive cervical cancer in Uganda

21 January 2018

1 reference

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

21 January 2018

1 reference

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

21 January 2018

1 reference

Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria

21 January 2018

1 reference

Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?

21 January 2018

1 reference

Human papillomavirus genotypes in cervical cancers in Mozambique

21 January 2018

1 reference

HPV infection in women with and without cervical cancer in Conakry, Guinea

21 January 2018

1 reference

Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study

21 January 2018

1 reference

Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix

21 January 2018

1 reference

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women

21 January 2018

1 reference

Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women

21 January 2018

1 reference

Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso

21 January 2018

1 reference

Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix].

21 January 2018

1 reference

New quadrivalent HPV vaccine developments

21 January 2018

1 reference

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

21 January 2018

1 reference

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years

21 January 2018

1 reference

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant

21 January 2018

1 reference

Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years

21 January 2018

1 reference

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

21 January 2018

1 reference

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

21 January 2018

1 reference

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

21 January 2018

1 reference

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

21 January 2018

1 reference

Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28425

1 reference

19 October 2017

1 reference